ERN1 and diffuse large B-cell lymphoma: Novel IRE1α inhibitor B-I09, when co-administered with BTK inhibitor ibrutinib, orchestrated apoptosis in several hematopoietic malignant cell lines, but little is known about the effect of the two drugs in DLBCL [65].